title: Stem cell therapy for CHD: towards translation.
abstract: Stem cell therapy has the optimistic goal of regenerating the myocardium as defined by re-growth of lost or destroyed myocardium. As applied to patients with heart failure, many confuse or limit the regenerative definition to just improving myocardial function and/or decreasing myocardial scar formation, which may not be the most important clinical outcome to achieve in this promising field of molecular medicine. Many different stem cell-based therapies have been tested and have demonstrated a safe and feasible profile in adult patients with heart failure, but with varied efficacious end points reported. Although not achieved as of yet, the encompassing goal to regenerate the heart is still believed to be within reach using these cell-based therapies in adult patients with heart failure, as the first-generation therapies are now being tested in different phases of clinical trials. Similar efforts to foster the translation of stem cell therapy to children with heart failure have, however, been limited. In this review, we aim to summarise the findings from pre-clinical models and clinical experiences to date that have focussed on the evaluation of stem cell therapy in children with heart failure. Finally, we present methodological considerations pertinent to the design of a stem cell-based trial for children with heart failure, as they represent a population of patients with very different sets of issues when compared with adult patients. As has been taught by many learned clinicians, children are not small adults!
authors.affiliation: Division of Cardiac Surgery,University of Maryland School of Medicine,Baltimore,Maryland,United States of America.
authors.forename: Brody
authors.initials: B
authors.lastname: Wehman
authors.affiliation: Division of Cardiac Surgery,University of Maryland School of Medicine,Baltimore,Maryland,United States of America.
authors.forename: Osama T
authors.initials: OT
authors.lastname: Siddiqui
authors.affiliation: Division of Cardiac Surgery,University of Maryland School of Medicine,Baltimore,Maryland,United States of America.
authors.forename: Rachana
authors.initials: R
authors.lastname: Mishra
authors.affiliation: Division of Cardiac Surgery,University of Maryland School of Medicine,Baltimore,Maryland,United States of America.
authors.forename: Sudhish
authors.initials: S
authors.lastname: Sharma
authors.affiliation: Division of Cardiac Surgery,University of Maryland School of Medicine,Baltimore,Maryland,United States of America.
authors.forename: Sunjay
authors.initials: S
authors.lastname: Kaushal
mesh_terms: D000818:Animals; D064987:Cell- and Tissue-Based Therapy / Q000379:methods*; D004195:Disease Models, Animal; D006330:Heart Defects, Congenital / Q000150:complications*; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D010372:Pediatrics; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D033581:Stem Cell Transplantation / Q000379:methods*
keywords: CHD; hypoplastic left heart syndrome; single ventricle; stem cell